Drugs

A recent CSHP webinar showed how hospitals can use national data to plan staffing and better understand rising drug costs, including an 85% increase in critical care spending per admission.

Study assesses whether holding certain DMARD therapy for two weeks after COVID-19 vaccination improves vaccine immunogenicity or worsens arthritis disease activity.

Identifying someone at risk through family testing before symptoms develop can be lifesaving, with treatment depending on the underlying condition.

A randomized trial compared periurethral and intravaginal application techniques in postmenopausal women with recurrent urinary tract infections.

The newly approved inhaler combines three COPD medications in a single device for long-term maintenance treatment.

Deaths of students at the University of Mississippi cast spotlight on the substance.

The policy leaves out women for now and faces questions from medical experts about the need and efficacy of such a program.

Get the info you need on this new product as part of our September drug news roundup.

Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027.

Alberta is the only province that legislates all schools to stock epinephrine devices that aren't designated for a particular student.